Thursday, December 15, 2022
1:00 pm - 2:00 pm

"Designing and Evaluating Pragmatic Trials of Behavioral Science-Based Interventions to Support Deprescribing"Julie Christine Lauffenburger, PharmD, PhDAssistant Professor in the Department of EpidemiologyJulie C. Lauffenburger, PharmD, PhD, is an Assistant Professor in Medicine at Harvard Medical School and an epidemiologist in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital.

Thursday, December 1, 2022
6:00 pm - 7:00 pm
Transplanting Hepatitis C virus infected kidneys into uninfected recipients: Past, present and futurePeter P.
Thinker-next logo

Funding: NIDDK
Investigator: Reese, P; Schaubel, D; Goldberg, D

The CRCU serves as the Data Coordinating Center for the THINKER-NEXT trial. The THINKER-NEXT trial, led by Peter Reese, MD and Douglas Schaubel PhD at The Perelman School of Medicine and David Goldberg, MD at the University of Miami in Florida, is a single arm open-label NIDDK-funded clinical trial.  The main objective of the study is to estimate the hepatitis C virus (HCV) cure rate after transplantation, using kidneys from HCV-infected deceased donors for HCV-negative recipients, followed by treatment with direct acting antivirals

RURAL logo

Funding: NHLBI
Investigator(s): Ramachandran, V

The Risk Underlying Rural Areas Longitudinal (RURAL) Cohort Study, coordinated by Vasan Ramachandran, MD, at The University of Texas at San Antonio (UTSA) and funded by the National Heart, Lung, and Blood Institute (NHLBI), is a six-year research project seeking to understand why people born in rural communities in the South live shorter and less healthy lives than do their counterparts elsewhere in the country. 

HOPE Helping People on Dialysis Manage Pain logo

Funding: NIDDK
Investigator: Dember, L.

The HOPE Trial is an NIDDK-funded randomized clinical trial to evaluate approaches to reducing pain and opioid use among patients with chronic pain who are receiving maintenance hemodialysis for end-stage renal disease.

Thursday, November 10, 2022
6:00 pm - 7:00 pm
"HIV Prevention Trials and the Challenges of Success"Deborah Donnell, PhDAffiliate Professor, Global HealthAffiliate Professor, Health Systems and Population HealthMember, Fred Hutchinson Cancer Research CenterUniversity of WashingtonDr Donnell is a biostatistician in the Vaccine and Infectious Disease Division at Fred Hutch, Seattle and the Department of Global Health at the University of Washington and the Principal Investigator of the HPTN Statistical and Data Management Center.
Thursday, November 3, 2022
5:00 pm - 6:00 pm
Data Safety Monitoring Boards in Vaccine Trials--The COVID Experience Jonathan M. Zenilman, MD Professor of Medicine Division of Infectious Disease Johns Hopkins University School of MedicineDr. Jonathan M. Zenilman is a professor of medicine, at the Johns Hopkins University School of Medicine. He also has as joint appointments in population family and reproductive health, international health and epidemiology at the Johns Hopkins University Bloomberg School of Public Health.Dr. Zenilman is known internationally for his work in infectious disease epidemiology.
Thursday, October 27, 2022
5:00 pm - 6:00 pm
"Misinformation About Vaccines on Social Media: A Study of the HPV Vaccine"Melanie L. Kornides, ScD, MPH, APRNAssistant Professor of NursingUniversity of Pennsylvania My interdisciplinary research focuses on strategies to combat misinformation and improve equitable uptake of vaccines and other forms of preventative health care." Dr. Kornides works with a multidisciplinary team to conduct research into misinformation, and its impact on vaccine acceptance. Disciplines include computer science, communication science, behavioral economics, and behavioral science.
Friday, November 11, 2022
12:00 am - 1:00 am
Thursday, October 20, 2022
5:00 pm - 6:00 pm
"Extending and Bending the HIV Care Continuum to Drive Public Health Action in New York City"Sarah L. Braunstein, PhD MPHAssistant Commissioner | Bureau of Hepatitis, HIV, and STI (BHHS) New York City Department of Health and Mental HygieneDr. Braunstein is the Director of HIV Epidemiology and Field Services Program at the New York City Department of Health and Mental Hygiene (DOHMH), and has extensive background and training in epidemiologic methods and research. Dr.
Subscribe to